{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:04:19Z","timestamp":1792109059662,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,26]]},"DOI":"10.7759\/cureus.63201","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T14:12:43Z","timestamp":1719411163000},"source":"Crossref","is-referenced-by-count":4,"title":["Successful Treatment With High-Dose Colchicine of a 101-Year-Old Patient Diagnosed With COVID-19 After an Emergency Cholecystectomy"],"prefix":"10.7759","author":[{"given":"Dimitar","family":"Bulanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanas","family":"Yonkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Arabadzhieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanyo","family":"Mitev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref2","article-title":"COVID-19 mortality in adults aged 65 and over: United States, 2020","volume":"446","author":"Tejada-Vera B","year":"2022","unstructured":"Tejada-Vera B, Kramarow EA. COVID-19 mortality in adults aged 65 and over: United States, 2020. NCHS Data Brief, no 446. Hyattsville, MD: National Center for Health Statistics. 2022, 446:1-8.","journal-title":"NCHS Data Brief, no 446. Hyattsville, MD: National Center for Health Statistics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2020.05.045","article-title":"The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects","volume":"21","author":"Bonanad C","year":"2020","unstructured":"Bonanad C, Garc\u00eda-Blas S, Tarazona-Santabalbina F, et al.. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020, 21:915-8. 10.1016\/j.jamda.2020.05.045","journal-title":"J Am Med Dir Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30269","article-title":"Complete, rapid resolution of severe bilateral pneumonia and acute respiratory distress syndrome in a COVID-19 patient: role for a unique therapeutic combination of inhalations with bromhexine, higher doses of colchicine, and hymecromone","volume":"14","author":"Mondeshki T","year":"2022","unstructured":"Mondeshki T, Bilyukov R, Tomov T, Mihaylov M, Mitev V. Complete, rapid resolution of severe bilateral pneumonia and acute respiratory distress syndrome in a COVID-19 patient: role for a unique therapeutic combination of inhalations with bromhexine, higher doses of colchicine, and hymecromone. Cureus. 2022, 14:e30269. 10.7759\/cureus.30269","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1273","article-title":"Effect of increasing doses of colchicine on the treatment of 333 COVID-19 inpatients","volume":"12","author":"Tiholov R","year":"2024","unstructured":"Tiholov R, Lilov AI, Georgieva G, Palaveev KR, Tashkov K, Mitev V. Effect of increasing doses of colchicine on the treatment of 333 COVID-19 inpatients. Immun Inflamm Dis. 2024, 12:e1273. 10.1002\/iid3.1273","journal-title":"Immun Inflamm Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35909","article-title":"Effect of an accidental colchicine overdose in a COVID-19 inpatient with bilateral pneumonia and pericardial effusion","volume":"15","author":"Mondeshki T","year":"2023","unstructured":"Mondeshki T, Bilyukov R, Mitev V. Effect of an accidental colchicine overdose in a COVID-19 inpatient with bilateral pneumonia and pericardial effusion. Cureus. 2023, 15:e35909. 10.7759\/cureus.35909","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.9734\/bpi\/codhr\/v10\/5310A","article-title":"Colchicine, bromhexine, and hymecromone as part of COVID-19 treatment - cold, warm, hot","volume":"10","author":"Mitev V","year":"2023","unstructured":"Mitev V, Mondeshki T, Marinov K, Bilukov R. Colchicine, bromhexine, and hymecromone as part of COVID-19 treatment - cold, warm, hot. Current Overview on Disease and Health Research. 2023, 10:106-14. 10.9734\/bpi\/codhr\/v10\/5310A","journal-title":"Current Overview on Disease and Health Research"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3897\/pharmacia.70.e112550","article-title":"Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended Paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib","volume":"70","author":"Mitev V","year":"2023","unstructured":"Mitev V. Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended Paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib. Pharmacia. 2023, 70:1177-93. 10.3897\/pharmacia.70.e112550","journal-title":"Pharmacia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54441","article-title":"High doses of colchicine act as \u201csilver bullets\u201d against severe COVID-19","volume":"16","author":"Lilov A","year":"2024","unstructured":"Lilov A, Palaveev K, Mitev V. High doses of colchicine act as \u201csilver bullets\u201d against severe COVID-19. Cureus. 2024, 16:e54441. 10.7759\/cureus.54441","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58164","article-title":"High-dose colchicine: Key factor in the treatment of morbidly obese COVID-19 patients","volume":"16","author":"Mondeshki T","year":"2024","unstructured":"Mondeshki T, Mitev V. High-dose colchicine: Key factor in the treatment of morbidly obese COVID-19 patients. Cureus. 2024, 16:e58164. 10.7759\/cureus.58164","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00435-5","article-title":"Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"9","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med. 2021, 9:1419-26. 10.1016\/S2213-2600(21)00435-5","journal-title":"Lancet Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-074373","article-title":"Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials","volume":"14","author":"Cheema HA","year":"2024","unstructured":"Cheema HA, Jafar U, Shahid A, et al.. Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2024, 14:e074373. 10.1136\/bmjopen-2023-074373","journal-title":"BMJ Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092615","article-title":"Efficacy of colchicine in the treatment of COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Toro-Huamanchumo CJ","year":"2022","unstructured":"Toro-Huamanchumo CJ, Benites-Meza JK, Mamani-Garc\u00eda CS, Bustamante-Paytan D, Gracia-Ramos AE, Diaz-V\u00e9lez C, Barboza JJ. Efficacy of colchicine in the treatment of COVID-19 patients: a systematic review and meta-analysis. J Clin Med. 2022, 11:2615. 10.3390\/jcm11092615","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub RA","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010, 62:1060-8. 10.1002\/art.27327","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman TL","year":"2020","unstructured":"Freeman TL, Swartz TH. Targeting the NLRP3 inflammasome in severe COVID-19. Front Immunol. 2020, 11:1518. 10.3389\/fimmu.2020.01518","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/13102818.2023.2288240","article-title":"What is the lowest lethal dose of colchicine?","volume":"37","author":"Mitev V","year":"2023","unstructured":"Mitev V. What is the lowest lethal dose of colchicine?. Biotechnol Biotechnol Equip. 2023, 37:2288240. 10.1080\/13102818.2023.2288240","journal-title":"Biotechnol Biotechnol Equip"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel E","year":"2006","unstructured":"Niel E, Scherrmann JM. Colchicine today. Joint Bone Spine. 2006, 73:672-8. 10.1016\/j.jbspin.2006.03.006","journal-title":"Joint Bone Spine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202406.0822.v1","article-title":"Colchicine- the divine medicine against COVID-19","author":"Mitev V","year":"2024","unstructured":"Mitev V. Colchicine- the divine medicine against COVID-19. Preprints. 2024, 2024060822. 10.20944\/preprints202406.0822.v1","journal-title":"Preprints"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2021.04.005","article-title":"Increased complications in patients who test COVID-19 positive after elective surgery and implications for pre and postoperative screening","volume":"223","author":"Prasad NK","year":"2022","unstructured":"Prasad NK, Lake R, Englum BR, et al.. Increased complications in patients who test COVID-19 positive after elective surgery and implications for pre and postoperative screening. Am J Surg. 2022, 223:380-7. 10.1016\/j.amjsurg.2021.04.005","journal-title":"Am J Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/v15071451","article-title":"Targeting inflammasome activation in viral infection: a therapeutic solution?","volume":"15","author":"Deng CH","year":"2023","unstructured":"Deng CH, Li TQ, Zhang W, Zhao Q, Wang Y. Targeting inflammasome activation in viral infection: a therapeutic solution?. Viruses. 2023, 15:1451. 10.3390\/v15071451","journal-title":"Viruses"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266526-successful-treatment-with-high-dose-colchicine-of-a-101-year-old-patient-diagnosed-with-covid-19-after-an-emergency-cholecystectomy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T14:12:47Z","timestamp":1719411167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266526-successful-treatment-with-high-dose-colchicine-of-a-101-year-old-patient-diagnosed-with-covid-19-after-an-emergency-cholecystectomy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.63201","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,26]]}}}